UBS on Friday changed its recommendation on Deutsche Boerse to "sell" from "neutral," while simultaneously lifting its price target to €300 from €265, an increase of 13% on the prior target. The brokerage said the stock now appears overvalued after a 49% gain so far this year, and that the new target implies roughly an 8% downside from the current share price, a rationale that underpinned the downgrade.
How UBS views the valuation
UBS noted that Deutsche Boerse has outpaced the broader market by 34% year to date, making it the top performer among European diversified financials within UBS's coverage universe. That strong performance has pushed the exchange operator's forward price-to-earnings multiple up to 24 times from 19 times at the end of 2025, placing the stock in its highest valuation decile, according to UBS.
The bank flagged a historical pattern it sees as relevant: over the past nine years, when the stock traded in its top valuation decile, the 12-month period that followed produced an average underperformance of 20% versus the market. UBS views that historical tendency as one reason why the current valuation is hard to justify.
Trading volumes and revenue trajectory
UBS expects some of this year's trading-related strength to fade. The brokerage pointed out that revenue-weighted trading volumes at Deutsche Boerse were up about 19% to 20% year on year in September and October, but that volume levels across several products normalized in November, with interest rate futures volumes dropping back quickly from a prior spike.
Trading and Clearing revenue increased 12% year on year in the first nine months of 2026, a gain that UBS said will make year-over-year comparisons more difficult in 2027. UBS projects Trading and Clearing revenue growth to slow to 4% in 2027 from 13% in 2026, and expects group revenue growth to decelerate to 5% from 11% as it regards a portion of this year’s volume gains as cyclical.
Market positioning and potential headwinds
The broker also cited market positioning as a factor that has supported Deutsche Boerse's share price. In the last two-plus months, Deutsche Boerse shares outperformed while European banks underperformed, a pattern UBS described as consistent with a historical tendency for the two groups to move in opposite directions.
UBS anticipates that an unwinding of that positioning could exert downward pressure on the stock’s valuation multiple and its share price in coming months.
Forecasts, deal impact and scenario analysis
Following the company’s third-quarter results, UBS modestly raised its earnings-per-share forecasts for 2027 and 2028 by 2%, to €13.81 and €15.30 respectively, largely reflecting stronger expectations for trading and clearing revenue. The brokerage said its €300 price target implies a valuation of 20 times projected 2028 earnings, versus about 21 times at current levels.
UBS added that Deutsche Boerse’s valuation remains difficult to justify even after incorporating the proposed acquisition of Allfunds; UBS expects that deal to contribute a mid-single-digit percentage uplift to the group's earnings per share. The broker outlined an upside scenario of €375 and a downside scenario of €240, which it said translate into a potential 16% gain and a 26% decline respectively from the November 18 closing price of €323.20.
Bottom line
UBS’s move combines a higher price target with a sell recommendation on the grounds that stretched valuation multiples, a possible reversion of cyclical trading volumes and the risk of positioning flows reversing could weigh on the stock. The bank’s scenario analysis presents a range of outcomes around its €300 target, underscoring the variability UBS sees in Deutsche Boerse’s near-term performance.